欧洲恶性雀斑样痣诊断与临床管理差异:欧洲皮肤科与性病科医师协会会员调查研究
该调查向欧洲皮肤科与性病科医师协会(EADV)3308名会员发放29题问卷,分析415份(12.5%)完整回复,评估恶性雀斑样痣(LM)的诊断方法与临床管理。结果显示诊断多联合临床诊断(65.7%)、皮肤镜(83.4%)和组织病理学(88.2%),61.0%采用单次钻孔活检取材;小于60岁患者首选手术(97.6%),大于70岁患者66.8%仍选手术,非手术选项如局部咪喹莫特(30.6%)、冷冻治疗(20.4%)、放疗(17.0%)和观察等待(19.6%)用于老年组。结论认为欧洲LM诊疗存在差异,手术仍最常用,作者建议未来研究关注患者偏好并比较手术与非手术治疗。
要点
- 诊断LM最常联合临床诊断(65.7%)、皮肤镜(83.4%)和组织病理学(88.2%)。
- 组织取材最常用单次钻孔活检,占61.0%。
- 小于60岁患者手术使用率97.6%,大于70岁患者手术使用率66.8%。
核心结论
- 调查显示欧洲LM诊断方法和治疗模式存在差异,手术仍是最常用选项,非手术选项如局部咪喹莫特和放疗最常用于老年患者。
- 作者建议未来研究关注患者偏好并比较手术与非手术治疗。
研究设计与样本
- 向欧洲皮肤科与性病科医师协会(EADV)3308名会员发放29题诊断方法与治疗选项问卷。
- 共纳入415份(12.5%)完整回复进行分析。
- 多数问题为多选题,每问可勾选多个答案。
主要发现
- 多数受访者联合使用临床诊断(65.7%)、皮肤镜(83.4%)和组织病理学(88.2%)诊断LM。
- 组织病理学评估取材最常用单次钻孔活检,占61.0%。
- 小于60岁LM患者最常用治疗为手术(97.6%)。
- 大于70岁LM患者中66.8%受访者仍偏好手术治疗。
- 大于70岁组使用非手术选项:局部咪喹莫特30.6%、冷冻治疗20.4%、观察等待19.6%、放疗17.0%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lentigo maligna (LM), a form of melanoma in situ, is treated to prevent progression to lentigo maligna melanoma (LMM). Surgical treatment is the gold standard. However, treatment guidelines are based on expert opinion, and comparative studies are lacking. OBJECTIVE: The objective of this study was to assess the diagnostic methods and clinical management of LM patients among European dermatologists and residents. METHODS: A survey consisting of 29 questions about diagnostic methods and treatment options used for LM patients was sent to 3308 members of the European Association of Dermatologists and Venereologists (EADV). RESULTS: Most questions were multiple choice, and multiple answers could be ticked per question. A total of N = 415 (12.5%) completed surveys were included in the analyses. A combination of clinical diagnosis (65.7%), dermatoscopy (83.4%) and histopathology (88.2%) is used by most respondents to diagnose LM. Tissue for histopathological evaluation was collected most often using a single punch biopsy in 61.0%. The most common treatment for LM patients <60 years of age is surgery (97.6%). For LM patients >70 years of age, 66.8% of the respondents preferred surgical treatment. Non-surgical options such as radiotherapy (17.0%), topical imiquimod (30.6%), watchful waiting (19.6%) or cryotherapy (20.4%) were used in this elderly group. Subanalysis showed that respondents who take into account patient preference used topical imiquimod, radiotherapy and watchful waiting more often. CONCLUSION: In conclusion, the results of this survey show that there is a variance in the diagnostic methods and treatment modalities used for LM across Europe. Surgery remains the most utilized option. However, non-surgical options, such as topical imiquimod and radiotherapy, are most often used for elderly patients. We recommend that future studies focus on patient preference and compare surgical to non-surgical therapy.
引用
- Tio D, Prinsen CAC, Dréno B, et al. Variation in the diagnosis and clinical management of lentigo maligna across Europe: a survey study among European Association of Dermatologists and Venereologists members. J Eur Acad Dermatol Venereol. 2018. PMID: 29419913. doi:10.1111/jdv.14850
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。